U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics Aug 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accendra Health, Celestica and Sionna Therapeutics, on Tuesday.
HIGHLIGHTS
* Accendra Health Inc ACH.N: Baird cuts to neutral rating |
* Celestica Inc CLS.N: Scotiabank resumes coverage with sector outperform rating |
* N-Able Inc NABL.N: RBC cuts to sector perform from outperform |
* Powerfleet Inc AIOT.O: Raymond James cuts to market perform from outperform |
* Sionna Therapeutics Inc SION.O: Jonestrading cuts to hold rating |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Aaon Inc AAON.O: Oppenheimer cuts target price to $125 from $145 |
* Abbvie ABBV.N: BNP Paribas raises target price to $247 from $218 |
* Abercrombie & Fitch Co ANF.N: Barclays raises target price to $114 from $78 |
* Abercrombie & Fitch Co ANF.N: Barclays raises to equal-weight from underweight |
* Accendra Health Inc ACH.N: Baird cuts target price to $1.5 from $6 |
* Accendra Health Inc ACH.N: Baird cuts to neutral rating |
* Accendra Health Inc ACH.N: Citigroup cuts target price to $1.5 from $4.5 |
* Accendra Health Inc ACH.N: Citigroup cuts to neutral from buy |
* ACV Auctions ACVA.N: BofA Global Research raises price objective to $6.00 from $5.60 |
* Aflac Incorporated AFL.N: KBW raises target price to $125 from $120 |
* Agilon Health Inc AGL.N: Citigroup raises target price to $115 from $105 |
* Agilon Health Inc AGL.N: Citigroup raises to neutral from sell |
* Agilon Health Inc AGL.N: Wells Fargo raises target price to $146 from $141 |
* Alamar Biosciences Inc ALMR.O: Stifel raises target price to $32 from $28 |
* Allstate Corp ALL.N: Citigroup cuts to sell from neutral |
* Allstate Corp ALL.N: Citigroup raises target price to $240 from $226 |
* Allstate Corp ALL.N: JP Morgan raises target price to $292 from $282 |
* Alpha Tau Medical Ltd DRTS.O: H.C. Wainwright raises target price to $16 from $15 |
* Altria Group Inc MO.N: Barclays cuts target price to $58 from $64 |
* American Financial Group, Inc. AFG.N: KBW raises target price to $153 from $148 |
* Applied Materials Inc AMAT.O: Bernstein raises target price to $675 from $525 |
* Applied Materials Inc AMAT.O: William Blair assumes coverage with market perform rating |
* Applied Optoelectronics Inc AAOI.O: Raymond James raises target price to $178 from $151 |
* Applovin APP.O: BofA Global Research cuts price objective to $400 from $430 |
* Applovin APP.O: BofA Global Research cuts to neutral from buy rating |
* Aspen Aerogels Inc ASPN.N: Barclays raises target price to $5 from $4 |
* AST Spacemobile Inc ASTS.O: BofA Global Research cuts price objective to $80 from $95 |
* AST Spacemobile Inc ASTS.O: UBS cuts target price to $78 from $80 |
* Astrana Health Inc ASTH.O: Truist Securities raises target price to $55 from $47 |
* Aura Biosciences Inc AURA.O: H.C. Wainwright cuts target price to $18 from $24 |
* Axsome Therapeutics Inc AXSM.O: Morgan Stanley raises target price to $251 from $242 |
* Axsome Therapeutics Inc AXSM.O: Wells Fargo raises target price to $256 from $255 |
* Best Buy Co., Inc. BBY.N: Truist Securities raises target price to $95 from $81 |
* Best Buy Co., Inc. BBY.N: Truist Securities raises to buy from hold |
* Best buy Company Inc BBY.N: Wells Fargo raises target price to $85 from $65 |
* BKV Corporation BKV.N: Barclays raises target price to $36 from $35 |
* Boeing BA.N: Argus Research raises to buy from hold |
* Bowman Consulting Group Ltd BWMN.O: B. Riley cuts to neutral from buy |
* Bridgebio pharma Inc BBIO.O: BofA Global Research raises price objective to $104 from $101 |
* Bridgebio pharma Inc BBIO.O: Morgan Stanley cuts target price to $97 from $98 |
* Bridgebio Pharma Inc BBIO.O: TD Cowen raises target price to $110 from $95 |
* Bridgebio Pharma Inc BBIO.O: Truist Securities raises target price to $107 from $102 |
* Bridgebio Pharma Inc BBIO.O: Wells Fargo raises target price to $102 from $98 |
* Brookdale Senior Living Inc. BKD.N: Barclays cuts target price to $17 from $18 |
* California Resources Corporation CRC.N: Barclays cuts target price to $77 from $80 |
* Cantor Equity Partners Ii Inc SECZ.N: Citizens initiates coverage with market outperform rating |
* Cantor Equity Partners Ii Inc SECZ.N: Citizens initiates coverage with PT $15 |
* Celestica Inc CLS.N: Canaccord Genuity cuts target price to $455 from $500 |
* Celestica Inc CLS.N: Scotiabank resumes coverage with sector outperform rating |
* Celestica Inc CLS.N: Scotiabank resumes coverage with target price $500 |
* Cencora Inc COR.N: Wells Fargo raises target price to $395 from $331 |
* Centene Corp CNC.N: Argus Research raises to buy from hold |
* Century Aluminum Company CENX.O: UBS initiates coverage with buy rating and PT $60 |
* CEVA Inc CEVA.O: Oppenheimer cuts target price to $38 from $42 |
* CEVA Inc CEVA.O: TD Cowen cuts target price to $45 from $55 |
* Cheniere Energy Inc LNG.N: TD Cowen raises target price to $290 from $280 |
* Cherry Hill Mortgage Investment Corporation CHMI.N: B. Riley cuts to neutral from buy |
* Cherry Hill Mortgage Investment Corporation CHMI.N: B. Riley raises PT to $3.1 from $3 |
* Cogent Biosciences Inc COGT.O: Guggenheim raises target price to $52 from $45 |
* Columbia Financial Inc CLBK.O: Piper Sandler cuts target price to $14 from $19 |
* Columbia Financial Inc CLBK.O: Piper Sandler raises to overweight from neutral |
* Compass Diversified Holdings CODI.N: B. Riley raises target price to $15 from $11 |
* Compass Diversified Holdings CODI.N: B. Riley raises to buy from neutral |
* Concentra Group Holdings Parent, Inc. CON.N: Wells Fargo raises target price to $40 from $28 |
* Conocophillips COP.N: Susquehanna raises target price to $161 from $155 |
* Coreweave Inc CRWV.O: JP Morgan raises target price to $110 from $105 |
* CVR Energy Inc CVI.N: JP Morgan raises target price to $32 from $25 |
* Definitive Healthcare DH.O: Morgan Stanley cuts target price to $1.50 from $2.50 |
* Delek US Holdings Inc DK.N: Mizuho raises target price to $66 from $60 |
* Dollar Tree Inc DLTR.O: BMO raises target price to $98 from $90 |
* Doordash DASH.O: Jefferies raises target price to $250 from $225 |
* Draftkings Inc DKNG.O: Berenberg raises target price to $27.5 from $26.4 |
* Draftkings Inc DKNG.O: Citigroup raises target price to $32 from $30 |
* eBay Inc EBAY.O: Jefferies raises target price to $80 from $75 |
* eBay Inc EBAY.O: UBS raises target price to $120 from $107 |
* Equitable Holdings Inc EQH.N: KBW raises target price to $67 from $62 |
* Eton Pharmaceuticals Inc ETON.O: H.C. Wainwright raises target price to $65 from $57 |
* Etsy Inc ETSY.N: Jefferies raises target price to $85 from $80 |
* Evolent Health Inc EVH.N: Citigroup cuts target price to $6 from $6.75 |
* Evolent Health Inc EVH.N: Citigroup raises to buy from neutral |
* Excelerate Energy Inc EE.N: Barclays raises target price to $43 from $41 |
* Expedia Group Inc EXPE.O: Jefferies raises target price to $375 from $310 |
* fair Isaac Corp FICO.N: Barclays cuts target price to $1700 from $1950 |
* Ferguson Enterprises FERG.N: Oppenheimer raises target price to $288 from $280 |
* Ferguson Enterprises Inc FERG.N: Barclays raises target price to $313 from $297 |
* Ferguson Enterprises Inc FERG.N: Bernstein raises target price to $325 from $310 |
* Ferguson Enterprises Inc FERG.N: UBS raises target price to $256 from $252 |
* Ferguson Enterprises Inc FERG.N: Wells Fargo raises target price to $295 from $285 |
* Five Below Inc FIVE.O: Mizuho raises target price to $260 from $220 |
* Goodrx Holdings Inc GDRX.O: Citigroup raises target price to $5 from $4 |
* GoPro Inc GPRO.O: Morgan Stanley cuts target price to $0.50 from $1.30 |
* Heron Therapeutics Inc HRTX.O: H.C. Wainwright cuts to neutral from buy |
* Hims & Hers Health Inc HIMS.N: BofA Global Research raises price objective to $32 from $30 |
* Hims & Hers Health Inc HIMS.N: Citigroup cuts target price to $33 from $35 |
* Hims & Hers Health Inc HIMS.N: Deutsche Bank raises target price to $26 from $25 |
* Hims & Hers Health Inc HIMS.N: Leerink Partners raises target price to $30 from $25 |
* Hims & Hers Health Inc HIMS.N: Morgan Stanley raises target price to $28 from $21 |
* Hims & Hers Health Inc HIMS.N: Needham raises target price to $42 from $35 |
* Hims & Hers Health Inc HIMS.N: TD Cowen raises target price to $30 from $25 |
* Hinge Health Inc HNGE.N: Truist Securities raises target price to $112 from $85 |
* Idexx Laboratories Inc IDXX.O: Barclays cuts target price to $710 from $800 |
* Innovex International Inc INVX.N: Barclays raises target price to $27 from $26 |
* Intuit Inc INTU.O: TD Cowen raises target price to $328 from $304 |
* Jabil Inc JBL.N: UBS raises to buy from neutral |
* Kenvue Inc KVUE.N: UBS cuts target price to $19 from $20 |
* Kinetik Holdings Inc. KNTK.N: Citigroup raises target price to $55 from $52 |
* KLA Corporation KLAC.O: Bernstein raises target price to $250 from $225 |
* L B Foster Co FSTR.O: B. Riley raises target price to $42 from $34 |
* Lam Research LRCX.O: Bernstein raises target price to $385 from $360 |
* Leidos LDOS.N: Citigroup raises target price to $161 from $138 |
* Life360 Inc LIF.O: D.A. Davidson raises target price to $47 from $42 |
* Life360 Inc LIF.O: UBS cuts target price to $60 from $64 |
* Lincoln Educational Services Corp LINC.O: Rosenblatt Securities cuts target price to $50 from $60 |
* Lincoln Electric Holdings Inc LECO.O: UBS initiates coverage with buy rating |
* Lincoln Electric Holdings Inc LECO.O: UBS initiates coverage with target price $340 |
* Lincoln National Corp LNC.N: JP Morgan raises target price to $49 from $42 |
* Lowe's Companies Inc LOW.N: Wells Fargo cuts target price to $245 from $255 |
* Lyft Inc LYFT.O: zephirin Group raises price objective to $17 from $16 |
* Marathon Petroleum Corporation MPC.N: Mizuho raises target price to $304 from $284 |
* Marinemax Inc HZO.N: B. Riley raises target price to $53 from $35 |
* Marketaxess Holdings Inc MKTX.O: KBW cuts to market perform from outperform |
* Marketaxess Holdings Inc MKTX.O: KBW raises target price to $167 from $150 |
* Matador Resources Company MTDR.N: Citigroup cuts target price to $60 from $68 |
* McKesson Corporation MCK.N: Wells Fargo raises target price to $933 from $812 |
* Medline Inc MDLN.O: Wells Fargo cuts target price to $34 from $45 |
* Merck & Co Inc MRK.N: Argus Research raises target price to $145 from $130 |
* Metagenomi Therapeutics, Inc. MGX.O: Wells Fargo cuts target price to $7 from $9 |
* Metlife Inc MET.N: JP Morgan raises target price to $108 from $106 |
* Mobility Global Inc MBGL.N: Citigroup initiates coverage with neutral rating; PT $23 |
* Mongodb Inc MDB.O: Citigroup raises target price to $545 from $455 |
* N-Able Inc NABL.N: RBC cuts target price to $4 from $6 |
* N-Able Inc NABL.N: RBC cuts to sector perform from outperform |
* National Energy Services Reunited Corp NESR.O: Barclays ups target price to $45 from $35 |
* National Energy Services Reunited Corp NESR.O: JP Morgan ups target price to $41 from $31 |
* National Energy Services Reunited Corp NESR.O: UBS raises target price to $45 from $36 |
* Neurogene Inc NGNE.O: Canaccord Genuity cuts target price to $166 from $180 |
* Newmont NEM.N: Raymond James raises target price to $131 from $128 |
* NIQ Global Intelligence Plc NIQ.N: Deutsche Bank raises target price to $15 from $14 |
* NIQ Global Intelligence Plc NIQ.N: Needham raises target price to $18 from $12 |
* NIQ Global Intelligence Plc NIQ.N: UBS raises target price to $17 from $16 |
* NIQ Global Intelligence Plc NIQ.N: Wells Fargo raises target price to $16.5 from $13 |
* Nkarta Inc NKTX.O: H.C. Wainwright cuts target price to $14 from $16 |
* Okta Inc OKTA.O: Oppenheimer raises target price to $170 from $125 |
* Optimum Communications Inc OPTU.N: Wells Fargo cuts target price to $0.75 from $1 |
* Oruka Therapeutics Inc ORKA.O: Leerink Partners raises target price to $179 from $162 |
* Par Pacific Holdings Inc PARR.N: Mizuho raises target price to $85 from $80 |
* Patrick Industries Inc PATK.O: Benchmark cuts target price to $115 from $135 |
* PDF Solutions Inc PDFS.O: Bernstein initiates coverage with outperform rating |
* PDF Solutions Inc PDFS.O: Bernstein initiates coverage with price target $65 |
* Phillips 66 PSX.N: Mizuho raises target price to $220 from $212 |
* Post Holdings Inc POST.N: Barclays cuts target price to $95 from $106 |
* Powerfleet Inc AIOT.O: Raymond James cuts to market perform from outperform |
* Primerica Inc PRI.N: KBW raises target price to $335 from $323 |
* Prudential Financial Inc PRU.N: KBW raises target price to $123 from $113 |
* Prudential Financial Inc PRU.N: Piper Sandler raises target price to $128 from $110 |
* Pubmatic Inc PUBM.O: Jefferies raises target price to $18 from $10 |
* Radnet Inc RDNT.O: B. Riley raises target price to $96 from $83 |
* Rapid7 Inc RPD.O: Barclays raises target price to $12 from $6.5 |
* Rapid7 Inc RPD.O: JP Morgan raises target price to $12 from $7 |
* Rapid7 Inc RPD.O: Raymond James raises target price to $15 from $8 |
* Rapid7 Inc RPD.O: Stifel raises target price to $13 from $7 |
* Rapid7 Inc RPD.O: UBS raises target price to $12 from $7 |
* Reinsurance Group of America Incorporated RGA.N: JP Morgan ups target price to $293 from $286 |
* Reinsurance Group of America Incorporated RGA.N: Piper Sandler raises PT to $274 from $261 |
* Republic Services Inc RSG.N: UBS raises target price to $235 from $233 |
* Revolution Medicines Inc RVMD.O: Truist Securities ups target price to $231 from $210 |
* RH RH.N: Wells Fargo raises target price to $225 from $175 |
* Riot Platforms Inc RIOT.O: Atb Cormark Capital Markets raises PT to $36 from $28 |
* Riot Platforms Inc RIOT.O: Bernstein raises target price to $35 from $30 |
* Riot Platforms Inc RIOT.O: H.C. Wainwright raises target price to $40 from $25 |
* Rocket Pharmaceuticals Inc RCKT.O: Leerink Partners cuts target price to $7 from $12 |
* Root Inc ROOT.O: Jefferies cuts to hold from buy; cuts target price to $58 from $78 |
* Simon Property Group Inc SPG.N: Jefferies cuts target price to $278 from $282 |
* Simon Property Group Inc SPG.N: Stifel raises target price to $209 from $194 |
* Sionna Therapeutics Inc SION.O: BTIG cuts to neutral from buy |
* Sionna Therapeutics Inc SION.O: Jonestrading cuts to hold rating |
* Sionna Therapeutics Inc SION.O: Wedbush cuts target price to $5 from $53 |
* Sionna Therapeutics Inc SION.O: Wedbush cuts to neutral from outperform |
* Skyward Specialty Insurance Group Inc SKWD.O: TD Cowen raises PT to $65 from $49 |
* SLR Investment Corp SLRC.O: B. Riley cuts to neutral from buy; cuts PT to $14 from $16 |
* Sprout Social Inc SPT.O: Barclays raises target price to $12 from $9 |
* Spyre Therapeutics Inc SYRE.O: BTIG raises target price to $132 from $112 |
* Standard Nuclear Inc STDN.N: Barclays initiates coverage with overweight rating |
* Standard Nuclear Inc STDN.N: Barclays initiates coverage with target price $17 |
* Strive Inc ASST.O: H.C. Wainwright cuts target price to $36 from $37 |
* Synopsys Inc SNPS.O: Wells Fargo cuts target price to $450 from $535 |
* Target Corp TGT.N: BMO raises target price to $150 from $130 |
* Target Corp TGT.N: Oppenheimer raises target price to $170 from $140 |
* Taskus Inc TASK.O: Morgan Stanley raises target price to $7.00 from $6.00 |
* Teleflex Incorporated TFX.N: UBS raises target price to $158 from $145 |
* Tenax Therapeutics Inc TENX.O: Canaccord Genuity cuts target price to $4 from $35 |
* Tenax Therapeutics Inc TENX.O: Leerink Partners cuts target price to $4 from $26 |
* Tenax Therapeutics Inc TENX.O: William Blair cuts to market perform rating |
* the Buckle Inc BKE.N: UBS cuts target price to $46 from $47 |
* the E.W. Scripps Co SSP.O: Wells Fargo cuts target price to $3.8 from $4.7 |
* The Gap Inc GAP.N: Barclays cuts target price to $20 from $26 |
* The Gap Inc GAP.N: Barclays cuts to equal-weight from overweight |
* The Home Depot Inc HD.N: Wells Fargo raises target price to $400 from $360 |
* The Pennant Group Inc PNTG.O: Wells Fargo raises target price to $46 from $45 |
* TIC Solutions Inc TIC.N: UBS raises target price to $12.5 from $11 |
* TIC Solutions Inc TIC.N: UBS raises to buy from neutral |
* Tidewater Inc TDW.N: zephirin Group raises price objective to $68 from $54 |
* Tripadvisor Inc TRIP.O: UBS cuts target price to $12 from $15 |
* Under Armour Inc UAA.N: Barclays cuts to underweight from equal-weight |
* Varex Imaging Corporation VREX.O: B. Riley cuts to neutral from buy |
* Varex Imaging Corporation VREX.O: B. Riley raises target price to $18.9 from $18 |
* Varex Imaging Corporation VREX.O: Oppenheimer cuts to perform from outperform |
* Vera Therapeutics Inc VERA.O: Wedbush cuts target price to $34 from $43 |
* Vertex Pharmaceuticals Incorporated VRTX.O: BofA Global Research adds stock to its US 1 list |
* Vertex Pharmaceuticals Incorporated VRTX.O: BofA Global Research raises price objective to $672 from $605 |
* Vertex Pharmaceuticals Incorporated VRTX.O: Jefferies raises PT to $633 from $610 |
* Viant Technology Inc DSP.O: UBS raises target price to $19 from $17 |
* Voya Financial Inc VOYA.N: JP Morgan raises target price to $109 from $105 |
* VSE Corporation VSEC.O: Deutsche Bank raises target price to $290 from $280 |
* Webtoon Entertainment Inc WBTN.O: JP Morgan cuts target price to $10 from $11 |
* Wendy'S Co WEN.O: JP Morgan raises target price to $7 from $6 |
* Williams-Sonoma Inc WSM.N: Wells Fargo raises target price to $240 from $190 |
* WW Grainger Inc GWW.N: Barclays raises target price to $1185 from $1166 |
* Zillow Group Inc ZG.O: BofA Global Research cuts price objective to $37 from $52 |
* Zoetis Inc ZTS.N: BNP Paribas cuts target price to $110 from $146 |
* Zoetis Inc ZTS.N: Citigroup cuts target price to $96 from $112 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Life360
See all newsAustralian shares rise on broad gains; Firmus shelving IPO boosts tech stocks
Partner of Australian missing in Nepal presses tech firms for access to location data (updated)
Partner of Australian missing in Nepal presses tech firms for access to data
SEC filing shows Softbank initiates stake in Capital One; sells 71.5% of its Taiwan Semi holdings
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics